A significant leap towards mass producing component of the blood that is responsible for clotting-platelets has been made by scientists.
A discovery has been made on how the body’s platelet factories can be grown in the laboratory. This discovery has been made by the teams from the University of Cambridge and the NHS.
According the discovery results, this could provide a newer source of platelets which is capable of stopping heavy bleedings, for example after a road accident.
But before beginning the trial, the researchers involved should make the process more efficient as possible.
If one donates blood, then the components are separated out into plasma, red blood cells, white blood cells and platelets so that the patients are provided with only the component that they need.
The most needed blood component is platelets and the patient should be provided with it after surgery, trauma, and leukemia therapy and in some cases of blood disorders such as hemophilia.
A consultant hematologist, Dr. Cendric Ghavaert said “We’re totally dependent on blood donation to produce those platelets.”
Cedric’s team has been working hard to grow the platelets mother cell that is found in the bone marrow and is responsible for manufacturing the clotting platelets. The mother cell is known as megakaryocytes.
According to the report published in the journal Nature communication, their break through was a set of chemical switches discovery that should be used to create the megakaryocytes in the lab. The team described their step as a major step forward.